ArticleBMC complementary medicine and therapies2025

Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial.

Babita Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.